These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 10714768

  • 1. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H, Saulnier R, Patryzkat A, Rahimi N, Raptis L, Rossiter J, Tremblay E, Elliott B.
    Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
    [Abstract] [Full Text] [Related]

  • 2. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC, Fan S, Walter KA, Abounader R, Williams JA, Rosen EM, Laterra J.
    Cancer Res; 2000 Aug 01; 60(15):4277-83. PubMed ID: 10945642
    [Abstract] [Full Text] [Related]

  • 3. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
    Rahimi N, Hung W, Tremblay E, Saulnier R, Elliott B.
    J Biol Chem; 1998 Dec 11; 273(50):33714-21. PubMed ID: 9837958
    [Abstract] [Full Text] [Related]

  • 4. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
    Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR.
    Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):247-52. PubMed ID: 11134526
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P, Miretti S, Starvaggi Cucuzza L, Martignani E, Baratta M.
    J Mol Endocrinol; 2010 Feb 02; 44(2):115-25. PubMed ID: 19850646
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
    Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP.
    Oncogene; 2002 Mar 28; 21(14):2201-11. PubMed ID: 11948403
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N, Chytil A, Shyr Y, Joly A, Moses HL.
    Mol Cancer Res; 2008 Oct 28; 6(10):1521-33. PubMed ID: 18922968
    [Abstract] [Full Text] [Related]

  • 9. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY, Chen B, Zhan YQ, Xu WX, Li CY, Yang RF, Zheng H, Yue PB, Larsen SH, Sun HB, Yang X.
    J Hepatol; 2004 Aug 28; 41(2):267-73. PubMed ID: 15288476
    [Abstract] [Full Text] [Related]

  • 10. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
    Derksen PW, de Gorter DJ, Meijer HP, Bende RJ, van Dijk M, Lokhorst HM, Bloem AC, Spaargaren M, Pals ST.
    Leukemia; 2003 Apr 28; 17(4):764-74. PubMed ID: 12682635
    [Abstract] [Full Text] [Related]

  • 11. Src activation regulates anoikis in human colon tumor cell lines.
    Windham TC, Parikh NU, Siwak DR, Summy JM, McConkey DJ, Kraker AJ, Gallick GE.
    Oncogene; 2002 Nov 07; 21(51):7797-807. PubMed ID: 12420216
    [Abstract] [Full Text] [Related]

  • 12. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells.
    Hung W, Elliott B.
    J Biol Chem; 2001 Apr 13; 276(15):12395-403. PubMed ID: 11278729
    [Abstract] [Full Text] [Related]

  • 13. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma.
    Saulnier R, Bhardwaj B, Klassen J, Leopold D, Rahimi N, Tremblay E, Mosher D, Elliott B.
    Exp Cell Res; 1996 Feb 01; 222(2):360-9. PubMed ID: 8598224
    [Abstract] [Full Text] [Related]

  • 14. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
    Fan S, Ma YX, Gao M, Yuan RQ, Meng Q, Goldberg ID, Rosen EM.
    Mol Cell Biol; 2001 Aug 01; 21(15):4968-84. PubMed ID: 11438654
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C.
    Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233
    [Abstract] [Full Text] [Related]

  • 16. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
    Mineo R, Costantino A, Frasca F, Sciacca L, Russo S, Vigneri R, Belfiore A.
    Endocrinology; 2004 Sep 01; 145(9):4355-65. PubMed ID: 15192042
    [Abstract] [Full Text] [Related]

  • 17. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
    Kakazu A, Chandrasekher G, Bazan HE.
    Invest Ophthalmol Vis Sci; 2004 Oct 01; 45(10):3485-92. PubMed ID: 15452053
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O, Cantley LC.
    Exp Cell Res; 2004 Jul 01; 297(1):224-34. PubMed ID: 15194438
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials.
    Li Y, Huang X, Zhang Q, Ma K.
    Mol Med Rep; 2013 Aug 01; 8(2):655-61. PubMed ID: 23778885
    [Abstract] [Full Text] [Related]

  • 20. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B.
    Cell Growth Differ; 1996 Feb 01; 7(2):263-70. PubMed ID: 8822210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.